Icb-1 Gene counteracts growth of ovarian cancer cell lines

Cancer Letters

Volumn 335, Issue 2, 2013, Pages 441-446

  Treeck, Oliver ^a   Schüler, Susanne ^a   Häring, Julia ^a   Skrzypczak, Maciej ^a,b   Lattrich, Claus ^a   Ortmann, Olaf ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Gene expression profiling; Gene knockdown; Icb 1 Gene; Ovarian cancer; Transcriptome analysis

Indexed keywords

CLAUDIN 16; ESTROGEN RECEPTOR ALPHA; KALLIKREIN; KALLIKREIN 10; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; ICB 1 GENE; OVARY CANCER; PRIORITY JOURNAL; UPREGULATION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CLAUDINS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KALLIKREINS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84878218360     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.02.049     Document Type: Article

References (38)

1. Treeck O., Strunck E., Vollmer G. A novel basement membrane-induced gene identified in the human endometrial adenocarcinoma cell line HEC1B. FEBS Letters 1998, 425:426-430.
2. Peirce M.J., Brook M., Morrice N., Snelgrove R., Begum S., Lanfrancotti A., Notley C., Hussell T., Cope A.P., Wait R. Themis2/ICB1 is a signaling scaffold that selectively regulates macrophage toll-like receptor signaling and cytokine production. PLoS One 2010, 5:e11465.
3. Treeck O., Odani T., Itoh N., Imai H., Fujita S., Kohroki J., Nakanishi T., Diedrich K., Ortmann O., Tanaka K., Vollmer G. Detection of increased icb-1 transcript levels in maturing HL-60 cells: a novel marker for granulocytic and monocytic in vitro differentiation. Leukemia Research 2002, 26:765-769.
4. Haselberger M., Springwald A., Konwisorz A., Lattrich C., Goerse R., Ortmann O., Treeck O. Silencing of the icb-1 gene inhibits the induction of differentiation-associated genes by vitamin D3 and all-trans retinoic acid in gynecological cancer cells. International Journal of Molecular Medicine 2011, 28:121-127.
5. Treeck O., Kindzorra I., Pauser K., Treeck L., Ortmann O. Expression of icb-1 gene is interferon-gamma inducible in breast and ovarian cancer cell lines and affects the IFN gamma-response of SK-OV-3 ovarian cancer cells. Cytokine 2005, 32:137-142.
6. Bollmann J., Ortmann O., Treeck O. Expression of differentiation-associated gene icb-1 is estrogen-responsive in ovarian and breast cancer cell lines. The Journal of Steroid Biochemistry and Molecular Biology 2008, 109:16-21.
7. Konwisorz A., Springwald A., Haselberger M., Goerse R., Ortmann O., Treeck O. Knockdown of ICB-1 gene enhanced estrogen responsiveness of ovarian and breast cancer cells. Endocrine-Related Cancer 2010, 17:147-157.
8. Springwald A., Lattrich C., Seitz S., Ortmann O., Treeck O. Single nucleotide polymorphisms in human gene icb-1 and breast cancer susceptibility. Cancer Investigation 2009, 27:669-672.
9. K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods San Diego, Calif 25 (2001) 402-408.
10. Warde-Farley D., Donaldson S.L., Comes O., Zuberi K., Badrawi R., Chao P., Franz M., Grouios C., Kazi F., Lopes C.T., Maitland A., Mostafavi S., Montojo J., Shao Q., Wright G., Bader G.D., Morris Q. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Research 2010, 38:W214-W220.
11. Hill S.M., Rodgers C.S., Hulten M.A., Wilson A.P. Cytogenetics of a cell line derived from an ovarian papillary serous cystadenocarcinoma. Cancer Genetics and Cytogenetics 1984, 12:321-327.
12. Holt J.A., Waggoner S.E., Lee E.Y., Hubby M.M., Hamilton T.C. Serum CA 125 and survival of mice inoculated with ovarian carcinoma and treated with antiestrogen, estrogen, or progestin. Gynecologic Oncology 1987, 27:282-293.
13. King B.L., Carter D., Foellmer H.G., Kacinski B.M. Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines. The American Journal of Pathology 1992, 140:23-31.
14. Belandia B., Orford R.L., Hurst H.C., Parker M.G. Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. The EMBO Journal 2002, 21:4094-4103.
15. Levenson A.S., Svoboda K.M., Pease K.M., Kaiser S.A., Chen B., Simons L.A., Jovanovic B.D., Dyck P.A., Jordan V.C. Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Research 2002, 62:4419-4426.
16. Seth P., Porter D., Lahti-Domenici J., Geng Y., Richardson A., Polyak K. Cellular and molecular targets of estrogen in normal human breast tissue. Cancer Research 2002, 62:4540-4544.
17. Frasor J., Danes J.M., Komm B., Chang K.C., Lyttle C.R., Katzenellenbogen B.S. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 2003, 144:4562-4574.
18. Stender J.D., Kim K., Charn T.H., Komm B., Chang K.C., Kraus W.L., Benner C., Glass C.K., Katzenellenbogen B.S. Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation. Molecular and Cellular Biology 2010, 30:3943-3955.
19. Ikari A., Hirai N., Shiroma M., Harada H., Sakai H., Hayashi H., Suzuki Y., Degawa M., Takagi K. Association of paracellin-1 with ZO-1 augments the reabsorption of divalent cations in renal epithelial cells. Journal of Biological Chemistry 2004, 279:54826-54832.
20. Delmotte P., Degroote S., Lafitte J.J., Lamblin G., Perini J.M., Roussel P. Tumor necrosis factor alpha increases the expression of glycosyltransferases and sulfotransferases responsible for the biosynthesis of sialylated and/or sulfated Lewis x epitopes in the human bronchial mucosa. Journal of Biological Chemistry 2002, 277:424-431.
21. Joshi M.B., Philippova M., Ivanov D., Allenspach R., Erne P., Resink T.J. T-cadherin protects endothelial cells from oxidative stress-induced apoptosis. The FASEB Journal 2005, 19:1737-1739.
22. Racca A.C., Camolotto S.A., Ridano M.E., Bocco J.L., Genti-Raimondi S., Panzetta-Dutari G.M. Kruppel-like factor 6 expression changes during trophoblast syncytialization and transactivates sshCG and PSG placental genes. PLoS One 2011, 6:e22438.
23. Rangel L.B., Sherman-Baust C.A., Wernyj R.P., Schwartz D.R., Cho K.R., Morin P.J. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene 2003, 22:7225-7232.
24. Laios A., O'Toole S.A., Flavin R., Martin C., Ring M., Gleeson N., D'Arcy T., McGuinness E.P., Sheils O., Sheppard B.L., O'Leary J.J. An integrative model for recurrence in ovarian cancer. Molecular Cancer 2008, 7:8.
25. Hou J., Renigunta A., Konrad M., Gomes A.S., Schneeberger E.E., Paul D.L., Waldegger S., Goodenough D.A. Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. The Journal of Clinical Investigation 2008, 118:619-628.
26. Agarwal R., D'Souza T., Morin P.J. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Research 2005, 65:7378-7385.
27. Yousef G.M., Polymeris M.E., Yacoub G.M., Scorilas A., Soosaipillai A., Popalis C., Fracchioli S., Katsaros D., Diamandis E.P. Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Research 2003, 63:2223-2227.
28. Shvartsman H.S., Lu K.H., Lee J., Lillie J., Deavers M.T., Clifford S., Wolf J.K., Mills G.B., Bast R.C., Gershenson D.M., Schmandt R. Overexpression of kallikrein 10 in epithelial ovarian carcinomas. Gynecologic Oncology 2003, 90:44-50.
29. Rosen D.G., Wang L., Atkinson J.N., Yu Y., Lu K.H., Diamandis E.P., Hellstrom I., Mok S.C., Liu J., Bast R.C. Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecologic Oncology 2005, 99:267-277.
30. El Sherbini M.A., Sallam M.M., Shaban E.A., El-Shalakany A.H. Diagnostic value of serum kallikrein-related peptidases 6 and 10 versus CA125 in ovarian cancer. International Journal Of Gynecological Cancer 2011, 21:625-632.
31. Batra J., Tan O.L., O'Mara T., Zammit R., Nagle C.M., Clements J.A., Kedda M.A., Spurdle A.B. Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival. International Journal Of Gynecological Cancer 2010, 20:529-536.
32. White N.M., Chow T.F., Mejia-Guerrero S., Diamandis M., Rofael Y., Faragalla H., Mankaruous M., Gabril M., Girgis A., Yousef G.M. Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer. British Journal of Cancer 2010, 102:1244-1253.
33. Cheng L., Lu W., Kulkarni B., Pejovic T., Yan X., Chiang J.H., Hood L., Odunsi K., Lin B. Analysis of chemotherapy response programs in ovarian cancers by the next-generation sequencing technologies. Gynecologic Oncology 2010, 117:159-169.
34. Barnea E., Beer I., Patoka R., Ziv T., Kessler O., Tzehoval E., Eisenbach L., Zavazava N., Admon A. Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens. European Journal of Immunology 2002, 32:213-222.
35. Lurquin C., De Smet C., Brasseur F., Muscatelli F., Martelange V., De Plaen E., Brasseur R., Monaco A.P., Boon T. Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 1997, 46:397-408.
36. Shyian M., Gryshkova V., Kostianets O., Gorshkov V., Gogolev Y., Goncharuk I., Nespryadko S., Vorobjova L., Filonenko V., Kiyamova R. Quantitative analysis of SLC34A2 expression in different types of ovarian tumors. Experiment Oncology 2011, 33:94-98.
37. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling. Cell Death and Differentiation 2003, 10:45-65.
38. Treeck O., Belgutay D., Haring J., Schuler S., Lattrich C., Ortmann O. Network analysis of icb-1 gene function in human breast cancer cells. Journal of Cellular Biochemistry 2012, 113:2979-2988.